Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to CU20040179ApriorityCriticalpatent/CU23343A3/en
Publication of CU23343A3publicationCriticalpatent/CU23343A3/en
El objeto de la invención proporciona una composición de ziprasidona que comprende no más que aproximadamadamente 1000 ppm de ziprasidona desclorada, preferiblemente no más que aproximadamente 500 ppm de ziprasidona desclorada, y más preferiblemente no más que aproximadamente 100 ppm de ziprasidona desclorada. Se proporcionan también procedimientos para sintetizar y utilizar dichas composiciones de ziprasidona.The object of the invention provides a ziprasidone composition comprising no more than about 1000 ppm of dechlorinated ziprasidone, preferably no more than about 500 ppm of dechlorinated ziprasidone, and more preferably no more than about 100 ppm of dechlorinated ziprasidone. Methods for synthesizing and using said ziprasidone compositions are also provided.
CU20040179A2004-08-232004-08-23
ZIPRASIDONE COMPOSITION AND SYNTHETIC CONTROLS
CU23343A3
(en)
Piperidine derived compounds; Pharmaceutical composition and use for the treatment and / or prophylaxis of diseases selected from hypertension, congestive heart failure and renal failure, among others.
COMPOUNDS DERIVED FROM 4,5-BIS-ALQUILSULFANIL- [1,3] DITIOL-2-TIONA OR 4,5-BIS-ALQUILSULFANIL- [1,3] DITIOL-2-ONA; LUBRICANT COMPOSITION; USE OF SUCH COMPOSITION; AND METHOD.